Antiepileptic drug-induced lymphoproliferative disorder associated with acquired C1 esterase inhibitor deficiency and angioedema.
Schlaifer
D
D
Arlet
P
P
Montane de la Roque
P
P
Ollier
S
S
Abbal
M
M
Le Tallec
Y
Y
D000368:Aged; D000799:Angioedema / Q000139:chemically induced*; D002220:Carbamazepine / Q000009:adverse effects*; D003174:Complement C1 Inactivator Proteins / Q000172:deficiency*; D005260:Female; D006801:Humans; D015448:Leukemia, B-Cell / Q000139:chemically induced*; D008232:Lymphoproliferative Disorders / Q000139:chemically induced*; D010672:Phenytoin / Q000009:adverse effects*
D003174:Complement C1 Inactivator Proteins; D002220:Carbamazepine; D010672:Phenytoin